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Abstract
Objective: To compare the prophylactic efficacy of 1 g ceftriaxone with 1,5 g cefuroxime + 0.5 g metronidazole for febrile morbid­
ity and urinary tract infection in patients undergoing vaginal hysterectomy. Study design: A prospective, randomized, comparative, 
non-blinded study with at least 100 patients on each side. The two-sample /-test was used for testing equality o f two means and 
the x 2 test was used for pair differences. Results: Single dose cefuroxime + metronidazole and ceftriaxone were equally effective 
in preventing febrile morbidity postoperatively. Additionally ceftriaxone was more effective in sterilizing pre-operatively existing 
bacteriuria.
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1. Introduction
Patients undergoing vaginal hysterectomy with or 
without repair need antibiotic prophylaxis to prevent 
febrile morbidity and vaginal top infections. The effi­
cacy of single dose of some antibiotics has been proved 
comparable with multiple dose regimens over 12-24 h 
[1-4], Many antibiotics have been used but there is no 
general agreement about the most suitable antibiotic.
Wound infections after hysterectomy are often 
polymicrobial and it is commonly accepted that prophy­
laxis should be directed against aerobic and anaerobic 
bacteria. Cefuroxime in combination with metronida­
zole is often used in this field and there is some experi­
ence with a single dose regimen [5,6]. We compared the 
prophylactic efficacy of this regimen with that o f cef­
triaxone.
Ceftriaxone is a broad spectrum cephalosporin with a 
prolonged half-life in serum of approximately 8 h and its
* Corresponding author, Tel.: +31 58 866130; Fax: +31 58 866609.
spectrum includes most gram-negative rods, gram- 
positive cocci, except enterococci, and Bacteroides spe­
cies. Single dose ceftriaxone has proved to be as ef­
ficacious as three doses o f cefazolin [7], To our 
knowledge it has not previously been compared with a 
single dose of cefuroxime + metronidazole.
Most trials only deal with efficacy rates, side effects 
and direct costs of doses, but the additional effect on 
prevention of post-operative urinary tract infections in 
these women, which is the main complication and the 
reason for prolonged hospital stay, is seldom con- 
siderated. This aspect must be taken into account when 
comparing single dose regimens in prophylaxis, especial­
ly for drugs with short half life. In this trial we specially 
considered urinary tract infections.
2. Materials and methods
2.1. Patients
All consecutive patients undergoing vaginal hysterec­
tomy with or without repair were enrolled in the study
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after informed consent was obtained. Inclusion criteria 
for entry were: patients referred to our practice for vagi­
nal hysterectomy with or without a prolapse repair, if 
they had no antibiotics during the preceeding 2 days and 
if they had normal liver and kidney functions.
Patients were alternately allocated to one of the two 
regimens of prophylaxis. The study was stopped when at 
least 100 patients in each group were evaluable. The 
study period was from 1 March 1989 until 1 July 1993.
All patients were operated by three gynaecologists or 
by registrars under direct supervision, all using the same 
technique. Patients who underwent a vaginal hysterecto­
my without repair were given an indwelling urethral 
catheter which was routinely removed after 1 or 2 days. 
Patients who also underwent a repair normally were 
given a suprapubic urinary catheter at the end of the op­
eration which was removed after 7 days. Operation in­
dication, details and duration were recorded for each 
patient.
Rectal temperature readings were recorded twice 
daily postoperatively and patients were observed daily 
for signs of infection. Diagnosis and criteria for post­
operative infections were: (1) febrile morbidity (>  38 °C 
rectal temperature over 2 days, excluding the first 48 h); 
(2) cuff infection (clinically obvious signs of vaginal top 
or cuff infection with palpable abnormality, fever and 
purulent discharge); (3) urinary tract infection (UTI):
*
bacteriuria ( > 1 0  000 microorganisms/ml urine).
2.2. Antimicrobial prophylaxis
Patients received one dose of 1.5 g cefuroxime + 0.5
g metronidazole or 1 g ceftriaxone in 100 ml isotonic salt 
solution via 10 min i.v. infusion at the start of anaes­
thesia.
2.3. Bacteriology
Urine catheter samples were cultured qualitatively 
and quantitatively before operation, at catheter removal 
and on indication. A direct preparation was made and 
the urine was diluted and plated on blood agar and 
McConkey agar. After 24 h at 37 °C, the colonies were 
counted and the original number of organisms per ml 
was estimated. All significant organisms were identified 
and their susceptibilities to various antibiotics were 
determined.
Other materials were cultured according to routine 
methods for aerobic and anaerobic bacteria.
2.4. Statistical analysis
The Student’s i-test was used for testing equality o f  
two means and the x 2-test was used for pair differences 
(P < 0.05 was taken as indicating statistical signif­
icance).
3. Results
Two-hundred fifty-six women entered the study; 30 
patients were excluded from the evaluation because they 
did not receive the antibiotic according the protocol, or 
their preoperative or postoperative urine culture was not 
known, or they were not operated according to the pro-
Table 1 
Patients’ data
Cefuroxime + metronidazole 
( « -  114)
Pre-existing UTI
Ceftriaxone 
(n = 112) 
Pre-existing UTI
No Yes No Yes
Patients
n 98 16 103 9
Mean age (years) 55 71 56 64
Range (years) 28-88 52-81 32-88 40—82
Operation indications
Carcinoma in situ 1 1 —
Bleeding complaint 22 ----- 22
Pain 4 1 ........
Prolapse 71 16 79 9
Operation details
With prolapse repair 87 15 71 9
With Pereyra suspension 2 --------- 4 1
Mean duration (min) 75 79 76 74
Range 30-180 35-150 30-150 50-100
Postoperative course
Febrile morbidity 1 2 5
Vaginal top infection --------- _ w — — »...
UTI postoperatively 17 14 10 3
Mean hospital stay (postoperative days) 8.5 11.6 8.5 8.3
I
I
I
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Table 2
Relationship between prophylaxis, catheterisation procedures and urinary tract infection
Cefuroxime + metronidazole Ceftriaxone
(»=114) (n =112)
Pre-existing UTI Pre-existing UTI
No Yes No Yes
Number of patients 98 16 103 9
5-7 day suprapubic catheter 59 15 65 8
and postoperative UTI 14 14 8 2
< 2 day urethra catheter 33 --------- 35 1
and postoperative UTI 1 --------- 1 I
5-7 day urethra catheter 6 1 3 ----------
and postoperative UTI 2 1 1 ----------
tocol. So 226 patients were evaluable, of whom 25 had 
pre-existing urinary tract infection and 201 had not*
3,1. Clinical outcome 
Demographic data of the patients by prophylaxis 
group are given in Table 1. Patients with a pre-existing 
bacteriuria (n = 25) were significant older than the 
patients with no pre-existing bacteriuria (n = 201) (P <
0.01). Apart from that there were no significant differ­
ences in any of the parameters examined. Febrile mor­
bidity occured in three of 114 patients with cefuroxime 
+ metronidazole and in five of 112 patients with cef­
triaxone. None of the patients developed vagina cuff in­
fection. Urine tract infection occurred more frequently 
in the cefuroxime + metronidazole group (31 patients) 
than in the ceftriaxone group (13 patients) (P <  0.001). 
Twenty-five patients had pre-existing bacteriuria, 14 of 
those on cefuroxime + metronidazole (n = 16) versus 
three on ceftriaxone (n = 9) had still bacteriuria 
postoperatively (P <  0.01). Table 2 shows the two treat­
ment groups according to catheterisation procedures: 
patients with a suprapubic catheter and no pre-existing 
urinary tract infection receiving ceftriaxone had less 
urinary tract infection (8 of 65) than patients receiving 
cefuroxime + metronidazole (14 of 59), although the 
difference is not significant. In patients with a pre­
existing bacteriuria and a suprapubic catheter also, in 
the ceftriaxone regimen there were less urinary tract in­
fection (two of eight) than in the cefuroxime + metro­
nidazole regimen (14 of 15) (P <  0.001).
Enterococci and Escherichia coli were predominant 
pathogens in urine of patients treated with cefuroxime + 
metronidazole, enterococci were also the main patho­
gens o f urine of patients treated with ceftriaxone (Table 
3). The mean hospital stay was similar for those without 
pre-existing bacteriuria (about 8.5 days) and those on 
ceftriaxone with pre-existing bacteriuria, but was 
significantly longer for those with pre-existing bacter­
iuria on cefuroxime (11.6 days) (P <  0.02). Escherichia 
coli was the main pathogen in both treatments groups;
Table 3
Microorganisms involved in postoperative urinary tract infections
Microorganisms Urine cultures
Negative Positive
preoperative ly p re operatively
Cefuroxime
Post
Ceftriaxone
Post
Cefuroxime Ceftriaxone
Pre Post Pre Post
Staphylococcus aureus 1 ---------- ---------- --------- ---------- ----------
Enterococcus faecalis 7 7 1 1 --------- 3
Streptococcus agalactiae ---------- --------- 2 ---------- i ----------
Escherichia coli 8 --------- 1 2 1 2 6 ----------
Enterobacter hafnia 1 1 --------- ---------- 1 ----------
Proteus mirabilis ---------- --------- 1 1 I ----------
Pseudomonas aeruginosa ---------- 2 --------- ---------- ---------- ----------
Number of infections 1 7 10 16 14 9 3
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it persisted under cefuroxime treatment, but was 
eliminated under ceftriaxone (Table 3). Proteus mirabilis 
and Enterococcus faecalis persisted as well under
cefuroxime treatment.
All patients with postoperative urine tract infection 
were treated with appropriate drugs and cured.
4. Discussion
Infectious morbidity following vaginal hysterectomy 
has been significantly reduced by use of perioperative 
prophylactic antibiotics, Most antibiotic regimens have 
included one pre-operative dose following by two or 
three postoperative doses [3,4], The preoperative dose is 
the critical one and it might not be necessary to continue 
antibiotic treatment postoperatively [8]. A  limited num­
ber of postoperative trials have studied single dose 
regimens. Mostly one dose was compared with three or 
four doses of the same or another comparable drug, 
often cefazolin [3], Ceftriaxone has been compared with 
multidose cefazolin and no difference in efficacy or se­
lection of resistant isolates was found [3,7]. The authors 
found that the total costs for ceftriaxone were greater 
than for cefazolin and this led in 1991 to the recommen­
dation that cefazolin should remain the drug of choice 
for prophylaxis of infection in uncomplicated vaginal 
hysterectomy [3]. Stiver et al. [7] found 8% febrile mor­
bidity in 65 patients for ceftriaxone. In our study we 
found 5% febrile morbidity in 112 patients on ceftriax­
one. This figure is comparable with our findings for sin­
gle dose cefuroxime + metronidazole. In her thesis, 
Wttewaall-Evelaar [9] stated that perioperative prophy­
laxis do not prevent postoperative bacteriuria. In our 
study ceftriaxone seems to reduce the frequency of post­
operative urinary tract infections. Thirty-one women 
treated with cefuroxime (27%) vs, 13 treated with with 
ceftriaxone (12%) had to be treated for postoperative 
urine tract infection. A  total o f 25 women appeared to 
have a urinary tract infection before operation. They 
were all of older age and were operated for hysterectomy 
with repair. In fact, they had to be treated before, but 
the results of culture taken at admittance are mostly not 
available in time. Single dose ceftriaxone was sufficient 
to sterilize the urine in nine patients (eight infected with 
Enterobacteriaceae) althought it selected in three of 
them for enterococci, but there was no need for extra 
treatment and prolonged stay. On the contrary, single 
dose cefuroxime was insufficient to treat pre-existing 
urine tract infections by E. coli and P. mirabilis. Patients 
with these infections required extra treatment and had 
prolonged hospital stay by 3.3 days. Costs of extra treat­
ment and additional prolongation of hospital stay total­
ly offset the cost savings o f the cheaper regimen, 
cefuroxime + metronidazole.
The prolonged half life and subsequent prolonged ex­
posure to adequate drug concentration by ceftriaxone 
may explain the beneficial effect on preventing postop­
erative urine tract infection. This additional effect is an 
advantage over cefuroxime having a short half life. We 
had the same experience in a comparable trial with one 
dose ciprofloxacin, having also a long half life, where we 
found only 7% of women developing post-operative 
urinary tract infection [4], A three-dose regimen o f  
cefuroxime + metronidazole, also providing prolonged 
antibiotic coverage at adequate concentrations, revealed 
only 13% urinary tract infection postoperatively [4].
To prevent postoperative urinary tract infections by 
peri-operative (single dose) prophylaxis, drugs with a 
prolonged half life are preferred.
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